Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec 21:7:100.
doi: 10.1186/1750-1172-7-100.

Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis

Xiao-Dan Yao  1 , Xin Chen, Gao-Yuan Huang, Yan-Ting Yu, Shu-Tian Xu, Yang-Lin Hu, Qing-Wen Wang, Hui-Ping Chen, Cai-Hong Zeng, Da-Xi Ji, Wei-Xin Hu, Zheng Tang, Zhi-Hong Liu
Affiliations

Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis

Xiao-Dan Yao et al. Orphanet J Rare Dis. .

Abstract

Background: Pathologic studies play an important role in evaluating patients with Alport syndrome besides genotyping. Difficulties still exist in diagnosing Alport syndrome (AS), and misdiagnosis is a not-so-rare event, even in adult patient evaluated with renal biopsy.

Methods: We used nested case-control study to investigate 52 patients previously misdiagnosed and 52 patients initially diagnosed in the China Alport Syndrome Treatments and Outcomes Registry e-system.

Results: We found mesangial proliferative glomerulonephritis (MsPGN, 26.9%) and focal and segmental glomerulosclerosis (FSGS, 19.2%) were the most common misdiagnosis. FSGS was the most frequent misdiagnosis in female X-linked AS (fXLAS) patients (34.8%), and MsPGN in male X-linked AS (mXLAS) patients (41.2%). Previous misdiagnosed mXLAS patients (13/17, 76.5%) and autosomal recessive AS (ARAS) patients (8/12, 66.7%) were corrected after a second renal biopsy. While misdiagnosed fXLAS patients (18/23, 78.3%) were corrected after a family member diagnosed (34.8%) or after rechecking electronic microscopy and/or collagen-IV alpha-chains immunofluresence study (COL-IF) (43.5%) during follow-up. With COL-IF as an additional criterion for AS diagnosis, we found that patients with less than 3 criteria reached have increased risk of misdiagnosis (3.29-fold for all misdiagnosed AS patients and 3.90-fold for fXLAS patients).

Conclusion: We emphasize timely and careful study of electronic microscopy and COL-IF in pathologic evaluation of AS patients. With renal and/or skin COL-IF as additional criterion, 3 diagnosis criteria reached are the cutoff for diagnosing AS pathologically.

PubMed Disclaimer

References

    1. Grunfeld JP. The clinical spectrum of hereditary nephritis. Kidney Int. 1985;27(1):83–92. doi: 10.1038/ki.1985.14. - DOI - PubMed
    1. Alport AC. Hereditary familial congenital haemorrhagic nephritis. Br Med J. 1927;1(3454):504–506. doi: 10.1136/bmj.1.3454.504. - DOI - PMC - PubMed
    1. Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grunfeld JP. Genetic heterogeneity of Alport syndrome. Kidney Int. 1985;27(4):672–677. doi: 10.1038/ki.1985.63. - DOI - PubMed
    1. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ. et al.Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet. 1994;8(1):77–81. doi: 10.1038/ng0994-77. - DOI - PubMed
    1. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990;248(4960):1224–1227. doi: 10.1126/science.2349482. - DOI - PubMed

Publication types